Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same
US9579284B2 · kind B2 · utility
3Cited by
47References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2013 |
| Grant date | Feb 28, 2017 |
| Priority date | — |
| Expiry date | Feb 11, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/773
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure generally relates to therapeutic nanoparticles. Exemplary nanoparticles disclosed herein may include about 1 to about 20 weight percent of a mTOR inhibitor; and about 70 to about 99 weight percent biocompatible polymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.